Prognostic and predictive value of the peritoneal cancer index in primary advanced epithelial ovarian cancer patients after complete cytoreductive surgery: study of …

K Gasimli, EI Braicu, R Richter, R Chekerov… - Annals of surgical …, 2015 - Springer
Purpose The peritoneal cancer index (PCI) is used to refer gastrointestinal malignancy
patients to either palliative or curative management of their peritoneal carcinomatosis. The …

[HTML][HTML] The small-molecule inhibitor MRIA9 reveals novel insights into the cell cycle roles of SIK2 in ovarian cancer cells

M Raab, M Rak, R Tesch, K Gasimli, S Becker… - Cancers, 2021 - mdpi.com
Simple Summary The current standard therapy of ovarian cancers comprises a reductive
surgery followed by a combination of taxane-platinum-based primary chemotherapy …

[HTML][HTML] The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer

R Mandal, M Raab, F Rödel, A Krämer… - Cellular and Molecular …, 2022 - Springer
Cervical cancer is the fourth most frequently diagnosed and fatal gynecological cancer. 15–
61% of all cases metastasize and develop chemoresistance, reducing the 5-year survival of …

Pregnancy after laparoscopic surgery for endometriosis: How long should we wait? A retrospective study involving a long‐term follow up at a university endometriosis …

M Tahmasbi Rad, D Akpinar‐Isci… - … of Gynecology & …, 2023 - Wiley Online Library
Objective To find the factors that influence the time until pregnancy after laparoscopic
intervention and to evaluate the proper time to start assisted reproductive therapy (ART) …

Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer–results of a …

EI Braicu, K Gasimli, R Richter, M Nassir… - Anticancer …, 2014 - ar.iiarjournals.org
Aim: The aim of the current study was to analyze the type of variations in expression profiles
of matrix metalloproteinase 2 (MMP2), matrix metalloproteinase 9 (MMP9), tissue inhibitor of …

Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer

MZ Muallem, J Sehouli, R Richter… - International Journal of …, 2020 - ijgc.bmj.com
Objective Prediction of post-operative residual disease after ovarian cancer cytoreductive
surgery remains a topic of interest to gynecologic oncologists. The aim of this study was to …

[HTML][HTML] Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT)–a study of the TOC Consortium

EI Braicu, T Van Gorp, M Nassir, R Richter… - Journal of ovarian …, 2014 - Springer
Background Borderline tumors of the ovary (BOT) are a distinct entity of ovarian tumors,
characterized by lack of stromal invasion. Recent studies postulated that the presence of …

AGO score as a predictor of surgical outcome at secondary cytoreduction in patients with ovarian cancer

MZ Muallem, K Gasimli, R Richter… - Anticancer …, 2015 - ar.iiarjournals.org
Aim: The present study aimed to compare the outcome of secondary cytoreductive surgery
retrospectively in patients with positive and negative Arbeitsgemeinschaft Gynäkologische …

Lymph node involvement pattern and survival differences of FIGO IIIC and FIGO IIIA1 ovarian cancer patients after primary complete tumor debulking surgery: a 10 …

K Gasimli, EI Braicu, M Nassir, R Richter… - Annals of surgical …, 2016 - Springer
Objective The main goal of the current study was to compare survival differences among
subgroups of primary ovarian cancer patients in International Federation of Gynecology and …

Clinical outcome after completion surgery in patients with ovarian Cancer: the Charite experience

A Babayeva, EI Braicu, JP Grabowski… - International Journal of …, 2018 - ijgc.bmj.com
Objective The aim of this study was to estimate surgical outcome and survival benefit after
completion surgery. Methods We evaluated 164 patients with epithelial ovarian cancer who …